|
Sep 27
|
We Think Syndax Pharmaceuticals (NASDAQ:SNDX) Can Afford To Drive Business Growth
|
|
Aug 4
|
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
|
|
Aug 3
|
Syndax Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Clinical and Business Update
|